Wilfried Stuecker
Koeln, NW 50674, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients.
Journal: Methods in cell biology
Published: March 28, 2024
The Application of Evidence-Based Medicine in Individualized Medicine.
Journal: Biomedicines
Published: May 26, 2023
Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
Journal: Translational cancer research
Published: April 06, 2023
Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.
Journal: International journal of molecular sciences
Published: August 05, 2022
Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients.
Journal: Genes and immunity
Published: September 02, 2021
Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors.
Journal: Cancer immunology, immunotherapy : CII
Published: November 26, 2020
Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged.
Journal: Cancers
Published: October 28, 2020
Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies.
Journal: Expert review of anticancer therapy
Published: July 01, 2020
Evidence-Based Medicine in Oncology: Commercial Versus Patient Benefit.
Journal: Biomedicines
Published: June 10, 2020
Last Updated: 09/26/2026